Plasma exchange and glucocorticoids in anti-neutrophil cytoplasm antibody associated systemic vasculitis: a randomised controlled trial (PEXIVAS Australia) [ 2015 - 2018 ]

Research Grant

Researchers: Dr Chen Au Peh (Principal investigator) ,  A/Pr Carmel Hawley ,  Dr David Jayne ,  Prof Peter Kerr ,  Prof Peter Merkel

Brief description ANCA-associated vasculitis is a life-threatening disease. The PEXIVAS trial will investigate whether plasma exchange, in addition to immunosuppressive therapy and glucocorticoids, will reduce death and the development of severe kidney failure due to this disease. Additionally, the project will also look at whether using a reduced dose of glucocorticoids is just as effective as larger doses in lessening the infectious complications of treatment.

Funding Amount $AUD 420,110.45

Funding Scheme Project Grants

Notes Standard Project Grant